| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,718 |
3,454 |
$977K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,863 |
4,604 |
$777K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
687 |
649 |
$310K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,404 |
1,504 |
$176K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,700 |
1,646 |
$103K |
| 71046 |
Radiologic examination, chest; 2 views |
1,815 |
1,708 |
$85K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
844 |
818 |
$83K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,010 |
973 |
$72K |
| 80061 |
Lipid panel |
4,111 |
4,091 |
$47K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
355 |
317 |
$44K |
| 80053 |
Comprehensive metabolic panel |
9,193 |
8,250 |
$41K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,662 |
3,570 |
$36K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
995 |
947 |
$28K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,525 |
1,521 |
$28K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
441 |
441 |
$27K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,410 |
9,065 |
$27K |
| 36415 |
Collection of venous blood by venipuncture |
11,768 |
10,050 |
$23K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
92 |
90 |
$22K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,301 |
370 |
$21K |
| 97161 |
|
274 |
268 |
$18K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
163 |
91 |
$17K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,823 |
1,741 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
659 |
646 |
$15K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,035 |
964 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,893 |
1,883 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,122 |
1,946 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
249 |
220 |
$10K |
| 70450 |
Computed tomography, head or brain; without contrast material |
147 |
140 |
$9K |
| 97014 |
|
1,228 |
342 |
$9K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
41 |
39 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
183 |
144 |
$7K |
| 84439 |
|
1,041 |
1,015 |
$6K |
| 87081 |
|
1,482 |
1,466 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
375 |
375 |
$6K |
| 85610 |
|
2,489 |
2,172 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,480 |
2,279 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,029 |
986 |
$4K |
| 82607 |
|
434 |
432 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
13 |
$4K |
| 85027 |
|
943 |
921 |
$3K |
| 73630 |
|
131 |
114 |
$3K |
| 83735 |
|
2,180 |
1,857 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
53 |
53 |
$3K |
| 87077 |
|
513 |
499 |
$2K |
| 73564 |
|
56 |
53 |
$2K |
| 87186 |
|
435 |
422 |
$2K |
| 82043 |
|
454 |
450 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
80 |
80 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
80 |
80 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
47 |
43 |
$2K |
| 81001 |
|
2,974 |
2,814 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
57 |
54 |
$1K |
| 83690 |
|
1,606 |
1,410 |
$1K |
| 87631 |
|
237 |
232 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
314 |
284 |
$1K |
| 87088 |
|
482 |
454 |
$1K |
| 73610 |
|
68 |
66 |
$998.05 |
| 97162 |
|
27 |
26 |
$866.21 |
| 86140 |
|
628 |
594 |
$801.14 |
| 72110 |
|
15 |
15 |
$796.06 |
| 84450 |
|
846 |
817 |
$752.77 |
| 82570 |
|
196 |
188 |
$685.63 |
| 73130 |
|
25 |
24 |
$678.72 |
| 82150 |
|
908 |
795 |
$660.54 |
| 82728 |
|
67 |
67 |
$599.04 |
| 87070 |
|
71 |
69 |
$353.08 |
| 83540 |
|
75 |
75 |
$315.66 |
| 85730 |
|
1,170 |
1,089 |
$268.24 |
| 84484 |
|
1,005 |
883 |
$258.38 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
13 |
13 |
$257.09 |
| 73030 |
|
13 |
12 |
$255.60 |
| 80306 |
|
97 |
93 |
$246.18 |
| 82550 |
|
913 |
843 |
$192.75 |
| 83615 |
|
1,712 |
1,593 |
$154.18 |
| 83550 |
|
25 |
25 |
$144.98 |
| 87807 |
|
30 |
30 |
$134.67 |
| 84460 |
|
45 |
42 |
$125.99 |
| 84703 |
|
205 |
189 |
$83.75 |
| 81003 |
|
124 |
120 |
$83.12 |
| 82977 |
|
672 |
613 |
$77.39 |
| 81025 |
|
383 |
360 |
$55.77 |
| 85652 |
|
26 |
26 |
$30.30 |
| 87400 |
|
50 |
49 |
$25.98 |
| 85651 |
|
12 |
12 |
$22.07 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
203 |
199 |
$20.26 |
| 85007 |
|
15 |
12 |
$19.00 |
| 85379 |
|
30 |
26 |
$16.36 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,900 |
1,644 |
$1.16 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
255 |
231 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
118 |
115 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
27 |
20 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
47 |
46 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13 |
12 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
38 |
38 |
$0.00 |
| A9270 |
Non-covered item or service |
770 |
521 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
232 |
221 |
$0.00 |
| J3490 |
Unclassified drugs |
117 |
74 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
69 |
57 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
114 |
90 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$0.00 |